Simon Toy on addressing common challenges in the workplace

How to address common challenges in the workplace

Is your organisation 2019 ready? Simon Toy, Managing Director of Performance Associates discusses addressing common challenges in the workplace As 2018 winds to an end, many...
Sandy Lindsey National Implementation Lead Manager, Vaccines, MSD

What is the role of a National Implementation Lead Manager?

Sandy Lindsey, National Implementation Lead Manager, Vaccines, MSD, joint winner of the Account Project Pf Award 2018, on how her role is really all...
Susanne Schaffert, Ph.D., President, AAA, an established Novartis executive, named new CEO, Novartis Oncology

Novartis announces new CEO of Oncology Business Unit

Novartis have appointed Susanne Schaffert, Ph.D., as the new CEO of Novartis Oncology  Novartis announced that Susanne Schaffert, Ph.D., currently President, Advanced Accelerator Applications (AAA), a...
transforming engagement for precision medicine with the cloud

Maxwellia expand their team with two new appointments

Maxwellia has expanded their team of switch experts with two new appointments following their relocation to the Alderley Park Accelerator. 
Vonnie Alexander as non-executive director

Synergy Vision appoints Vonnie Alexander as non-executive director

Synergy Vision is gearing up for global growth with the appointment of Vonnie Alexander as non-executive director.  This comes after the Australian office doubled business...
Woman interviewing man at a desk demonstrating a successful key account manager

How to be a successful key account manager

Pf asked two consultants from top pharma recruitment consultancies for their views on what it takes to be a successful key account manager.   Andy Boyd, Senior...
Dr Annalisa Jenkins & Lord Michael Grade become advisors to AKL

Dr Annalisa Jenkins & Lord Michael Grade become advisors to AKL

AKL Research and Development (AKLRD), a company developing an investigational osteoarthritis (OA) medicine, has announced the appointment of Dr Annalisa Jenkins and Lord Michael...
CF Future Care

CF Future Care: Putting people with CF in the driving seat

Dr Su Madge is the driving force behind a digital platform called CF Future Care, putting people with cystic fibrosis (CF) in the driving...

Healthcare Communications Association appoints two new members

The Healthcare Communications Association (HCA) has announced two new members joining its Executive Committee (EC). Effie Baoutis will spearhead the organisation’s presence and activity across...

Makara Health promote Helen Laurence to Director

UK-based international healthcare communications agency, Makara Health, has promoted senior PR and communications specialist Helen Laurence to Director, reinforcing its leadership team as it...

Latest articles

Investigational therapy has potential to become first oral GLP-1 receptor agonist for those living with type 2 diabetes

Novo Nordisk presents oral semaglitude data at ENDO

Oral semaglutide 7 mg and 14 mg doses showed superior reductions in blood sugar and weight compared to sitagliptin at 26 weeks in data...
Pf Award Winners

Pf Award Winners on the positive patient outcomes that come from working together

The winners of the Joint Working Pf Award 2018, Senior Coloplast Care Nurse Ruth Christer and NHS Partnership Manager, Coloplast, Jonathan Walker, on the...
Brain scan image: Detecting and managing atrial fibrillation

Detecting and managing atrial fibrillation

The ‘Podiatry and Atrial Fibrillation – Save a life, stop a stroke’ webinar was created to improve the detection and management of atrial fibrillation,...

Popular articles

Brain scan image: Detecting and managing atrial fibrillation

Detecting and managing atrial fibrillation

The ‘Podiatry and Atrial Fibrillation – Save a life, stop a stroke’ webinar was created to improve the detection and management of atrial fibrillation,...
Samsung Bioepis Announces Three-year Follow-up Data for Biosimilar ONTRUZANT® (trastuzumab) in Early or Locally Advanced HER2-positive Breast Cancer

Samsung Bioepis announces three-year follow-up data for biosimilar ONTRUZANT® (trastuzumab)

Samsung Bioepis announces three-year follow-up data for biosimilar ONTRUZANT® (trastuzumab) in early or locally advanced HER2-positive breast cancer. Samsung Bioepis has announced the findings of...
The future of genomics

The future of genomics and precision medicine

How is the use of genomics data enhancing our medical understanding and what does this mean for the future of precision medicine? Genomics is one of...
Investigational therapy has potential to become first oral GLP-1 receptor agonist for those living with type 2 diabetes

Novo Nordisk presents oral semaglitude data at ENDO

Oral semaglutide 7 mg and 14 mg doses showed superior reductions in blood sugar and weight compared to sitagliptin at 26 weeks in data...
Image of graduates: skills shortage in life sciences

Addressing the skills shortage in life sciences

How can collaboration help to fill the skills shortage gap to ensure that the UK can compete in the global future of life sciences? The...